Overview
Kisqali (Ribociclib) is a prescription medication used to treat certain types of breast cancer, specifically hormone receptor-positive, HER2-negative breast cancer in combination with aromatase inhibitors. It works as a CDK4/6 inhibitor that helps prevent cancer cell division by blocking proteins that are essential for cancer cell growth. This medication is typically used for postmenopausal women or men in combination with other cancer treatments. Kisqalican slow the progression of cancer, improving the patient's quality of life.





